Le Lézard
Classified in: Health
Subject: POLITICS

Stigma costs lives: MHCC challenges federal candidates to lead debate on mental health in 2019 election


From Mental Health Commission of Canada

OTTAWA, Sept. 12, 2019 (GLOBE NEWSWIRE) -- With the federal election officially underway, the Mental Health Commission of Canada (MHCC) is challenging all parties to lead a factual, respectful debate on mental health to address the urgent needs of 7.5 million Canadians living with mental illness.

The language used in this debate is just as important as the debate itself. That's why the MHCC is releasing resources today to help candidates and leaders in their discussions with voters on the doorstep, at town halls, and during debates. A handbook is also being sent to newsrooms across the country to help journalists covering mental health issues in the campaign.

"Despite the progress we've made as a country in bringing mental health out of the shadows, too many conversations are still shaped by unhelpful, stigmatizing stereotypes," said Louise Bradley, MHCC President and CEO. "All parties, candidates and the public need to remember that when speaking about mental health, language matters. We know that stigma costs lives and we must challenge ourselves to eliminate it."

Too often, Canadians who live with mental health problems don't seek help for fear of being labelled, humiliated and shunned. Those who do come forward often have a hard time simply accessing treatment ? in some cases, having to wait up to 18 months for necessary help.

We can no longer afford to treat physical and mental health as separate issues. With a $50 billion-dollar dent to the Canadian economy every year and too many lives lost daily, now is the time to refocus the national spotlight on these important issues.

"While recent investments have been made, it will take a bold combination of funding increases, innovation and systemic reform to not only make up for the decades of not doing so but to make sure access to mental and physical health care are given the same priority," said Bradley. "With lives being lost every day, the government can and must lead."

As a federal, arms-length agency whose mandate is to take a national perspective on mental health, the MHCC is eager to work with the parliamentarians to achieve this long-overdue reform and to build solutions that will make a real difference for Canadians in need.

Quick facts

Contact
Media Relations
Mental Health Commission of Canada
613-683-3748
[email protected]

Language resources
Language Matters
Mindset: Reporting on Mental Health

Stay connected during #elxn43
Follow MHCC on Facebook
Follow MHCC on Twitter
Follow MHCC on LinkedIn

Stay Connected
Follow MHCC on Facebook
Follow MHCC on Twitter
Follow MHCC on LinkedIn
Follow MHCC on Instagram


These press releases may also interest you

at 14:06
On Wednesday, May 15, Red Door Community hosted their annual Celebrating Women Working and Living with Cancer Luncheon at the Metropolitan Club in New York City. The event raised more than $300,000 while shining a light on the women who inspire us...

at 14:05
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

at 13:27
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

at 11:03
Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRMtm System,* the first modular cardiac rhythm management (CRM) system that consists of the EMBLEMtm Subcutaneous...

at 08:35
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

at 07:05
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...



News published on and distributed by: